Medistep Healthcare Ltd
Complete IPO details, including price band, financials, subscription status, and key insights.
Participate in the Medistep Healthcare Ltd IPO with full transparency. Review issue details, company fundamentals, and financial performance, and apply securely through Alice Blue.
IPO Snapshot
Key metrics and details at a glance.
Price Band
₹43
Per ShareLot Size
3000 Shares
Minimum Investment
₹1,29,000
Issue Size
₹16.1 Cr
Face Value
₹10
Per ShareIPO Type
Fixed Price - SME
Retail Quota
49.96%
QIB Quota
0%
NII Quota
50.04%
IPO Timeline
Important dates for your applying strategy.
Subscription Status
Live demand across investor categories.
Track real-time subscription levels:
*Real-time data subject to exchange updates
Medistep Healthcare Ltd
Business model, operations, and market positioning.
Promoter Holding (Pre-Issue)
93.62%
Promoter Holding (Post-Issue)
68.96%
Issue Type
Fixed Price - SME
ISIN
INE0UOY01019
About the Company
Medistep Healthcare Limited is a Pharmaceutical Company that has carved a niche in the Healthcare Industry through its experience in manufacturing Sanitary pads, Energy powder and trading a diverse range of pharmaceutical products, Nutraceutical products, Intimate Products and surgical products through distribution network.
Industry Overview
The Indian pharmaceutical industry has proved to be the major player in the domestic and international market. This supremacy has been achieved through an enduring process of manufacturing, competitive prices practice, and highly skilled staff. One of the major strategies for Indian pharma sector in terms of growth is its global expansion which is the key driver of this industry's performance. The degree to which Indian pharma progresses towards the international level depends crucially on its flexibility and robustness in the global health arena.
Company History
Our Company was originally incorporated on June 05, 2023 as `Medistep Healthcare Limited', as a Public limited company under the Companies Act, 2013 bearing Corporate Identification Number U21009GJ2023PLC141841 pursuant to Certificate of Incorporation issued by Registrar of Companies, Ahmedabad. Thereafter our company acquired the business of Proprietorship Concern of one of our Promoter Mrs. Prajapati Hetalben Girdharilal viz, MG Pharma through the business transfer agreement dated July 02, 2023. Subsequently the business of the sole proprietorship firm was transferred into Medistep healthcare Limited.
Products & Services
- Medistep Healthcare Limited is a Pharmaceutical Company that has carved a niche in the Healthcare Industry through its experience in manufacturing Sanitary pads, Energy powder and trading a diverse range of pharmaceutical products.
Growth Strategy
- Market Analysis and Targeting.
- Product Development and Innovation.
- Quality and Regulatory Compliance.
- Distribution and Sales Channels.
- Customer satisfaction.
- Sustainability and Ethical Practices.
- Competitive Analysis.
Customer Base
Wholesaler and Retailer
Financial Performance
Revenue, profit after tax and total assets across the last 3 reported financial years.
Revenue
Amount in ₹ crore
Profit After Tax (PAT)
Amount in ₹ crore
Total Assets
Amount in ₹ crore
Figures in ₹ crore, on a standalone basis, as reported for FY24 to FY26.
Objects of the Issue
How the company plans to utilize IPO proceeds.
Use of Proceeds
The funds raised through this IPO will be used for:
Initial public offering of up to 37,44,000 equity shares of Rs. 10/- each ("Equity Shares") of Medistep Healthcare Limited ("the "Company") for cash at a price of Rs. 43/- per equity share (the "Issue Price"), aggregating to Rs. 16.10 crores ("the Offer"). Out of the offer, 1,89,000 equity shares aggregating to Rs. 0.81 crores will be reserved for subscription by market maker ("Market Maker Reservation Portion"). The offer less the market maker reservation portion i.e. offer of 35,55,000 equity shares of face value of Rs. 10.00/- each at an issue price of Rs. 43/- per equity share aggregating to Rs. 15.29 crores is hereinafter referred to as the "Net Offer". The offer and the net offer will constitute 26.35 % and 25.02 %, respectively of the post issue paid up equity share capital of the company. The face value of the equity shares is Rs. 10/- each and the issue price of Rs. 43/- the offer price is 4.3 times of the face value of the equity shares. Bid can be made for a minimum of 2 lot (lot size consist of 3000 equity shares each) and in multiples of 3000 equity shares thereafter.
*Subject to approvals and market conditions.
Strengths & Risks
Key competitive advantages and factors to consider before investing.
- Experienced Promoters and Senior Management with extensive domain knowledge.
- Quality assurance and control.
- Market Potential.
- Investment in latest technology and maintain our edge in the market.
- The company provide its goods majorly in Gujarat, any adverse changes in the conditions affecting these regions can adversely affect its business, financial condition and results of operations.
- The company manufacturing facility are subject to operational risks. Any slowdown or shutdown in its manufacturing operations could adversely affect the company business, financial condition and results of operations.
- The company relies on domestic third-party suppliers for the supply of raw materials and any delay, interruption or reduction in such supply could adversely affect its business, results of operations, financial condition and cash flows.
- The company is subject to extensive government regulations and if its fail to obtain, maintain or renew the company statutory and regulatory licenses, permits and approvals required to operate its business, the company business, financial condition, results of operations and cash flows may be adversely affected.
- The Company is dependent on few numbers of customers for sales. The loss of any of this large customer may affect its revenues and profitability.